Exploring Oral Systemic Therapies for Plaque Psoriasis: Efficacy, Safety, and Clinical Considerations

Opinion
Podcast

Lauren Miller, MPAS, PA-C; Jayme M. Heim, MSN FNP-BC, and Kirk Gautier, PA-C, discuss recent advancements in plaque psoriasis treatment, focusing on novel oral systemic therapies like the TYK-2 inhibitor deucravacitinib and its clinical trial data, to inform therapeutic decisions for this systemic disease.

Recent Videos
Sherona Bau, NP | Credit: UCLA Health
Discussing Interim Findings on Nemolizumab for Atopic Dermatitis, with Diamant Thaçi, MD
Jessica Crimaldi, NP | Credit: Jessica Crimaldi on LinkedIn
Harpreet Bhatia, MD: Benefits of Universal Screening for Lp(a) Levels
Considering Viral Infections in Patients With Rheumatic Disease With Leonard Calabrese, DO
Related Content
Service Members Fail to Receive Suitable Follow-up Care for Fibromyalgia

Service Members Often Fail to Receive Suitable Follow-up Care for Fibromyalgia

Victoria Johnson
October 1st 2024
Article
The Medical Sisterhood: Confronting Imposter Syndrome, with Tina Bhutani, MD, MAS

The Medical Sisterhood: Confronting Imposter Syndrome, with Tina Bhutani, MD, MAS

Mona Shahriari, MD, FAAD
September 30th 2024
Podcast
Family Heart Foundation Launches Cholesterol Connect: Free At-Home Lipid Screening

Family Heart Foundation Launches Cholesterol Connect: Free At-Home Lipid Screening

Chelsie Derman
September 30th 2024
Article
Introducing The Medical Sisterhood, with Mona Shahriari, MD

Introducing The Medical Sisterhood, with Mona Shahriari, MD

Mona Shahriari, MD, FAAD
September 16th 2024
Podcast
Study Finds Greater Pain Reduction With JAKis Over bDMARDs in Third-Line RA

Study Finds Greater Pain Reduction With JAKis Over bDMARDs in Third-Line RA

Victoria Johnson
September 30th 2024
Article
Christopher Bowlus, MD | Credit: UC Davis Health

Positive Phase 2a Data Suggest Disease-Modifying Potential of CNP-104 in PBC

Abigail Brooks, MA
September 30th 2024
Article
© 2024 MJH Life Sciences

All rights reserved.